Accretion Nutraveda IPO Shows Moderate Response, Subscribed 1.83x on Day 3

Accretion Nutraveda Limited's initial public offering (IPO) has demonstrated moderate investor interest through its third and final day of subscription. The stock price band is set at ₹122-129 per share. The ₹24.77 crore IPO reached 1.83 times by 5:09:54 PM on day three.

Accretion Nutraveda IPO subscription reached moderate 1.83 times on day three. It was led by Individual Investors (2.19x), Non-Institutional Investors (2.08x), and Qualified Institutional Buyers Ex-Anchor (1.01x). Total applications reached 818.

Invest in Indian Markets and Unlock Future Potential With 5paisa!

Open Account Now

Subscription Status of Accretion Nutraveda IPO:

Here are the subscription details for Accretion Nutraveda IPO as of Day 3 (January 30, 2026, 5:09:54 PM):

Key Highlights - Day 3:

• Overall subscription reached moderate 1.83 times, showing substantial improvement from day two's 0.64 times
• Individual investors displaying moderate confidence at 2.19 times, building substantially from day two's 0.43 times, indicating moderate retail demand for this SME IPO
• Non-institutional investors showing moderate performance at 2.08 times, building substantially from day two's 0.64 times, indicating improved HNI appetite for this Ayurvedic and nutraceutical products manufacturer
• Qualified institutional buyers (ex-anchor) displaying moderate performance at 1.01 times, marginally improving from day two's 0.99 times, indicating measured institutional interest
• Cumulative bid amount reached ₹30.24 crores, modestly exceeding the net offer size of ₹23.53 crores (excluding anchor and market maker portions) by approximately 1.3 times

Accretion Nutraveda IPO - Day 2 Subscription at 0.64 Times

Key Highlights - Day 2:

• Overall subscription reached weak 0.64 times, showing substantial improvement from day one's 0.20 times
• Qualified institutional buyers displaying moderate performance at 0.99 times, building substantially from day one's 0.00 times
• Non-institutional investors showing weak performance at 0.64 times, building marginally from day one's 0.45 times

Accretion Nutraveda IPO - Day 1 Subscription at 0.20 Times

Key Highlights - Day 1:

• Overall subscription reached weak 0.20 times, showing very cautious initial investor interest
• Non-institutional investors displaying weak performance at 0.45 times, indicating weak HNI appetite
• Individual investors showing weak confidence at 0.21 times, indicating weak retail interest
• Qualified institutional buyers displaying negligible performance at 0.00 times, indicating no institutional interest on day one

About Accretion Nutraveda Limited

Incorporated in 2021, Accretion Nutraveda is engaged in the manufacturing of Ayurvedic and nutraceutical products in various dosage forms, including tablets, capsules, oral liquids, powders, oils, and external preparations like balms, creams, and gels. The company operates as a contract development and manufacturing organisation (CDMO), serving both domestic and international markets such as Sri Lanka, Singapore, and the USA. Its products combine classical Ayurvedic principles with modern nutraceutical science to address areas like liver care, women's health, bone and joint health, cognitive support, and respiratory wellness. Business verticals include domestic sales and merchant exports (loan license basis) contributing 96.62% of total revenue in FY 2024-25, and direct exports contributing 3.38%, showing consistent growth.